rs764343937
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000520.6(HEXA):c.460-1G>T variant causes a splice acceptor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000828 in 1,570,824 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000520.6 splice_acceptor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HEXA | NM_000520.6 | c.460-1G>T | splice_acceptor_variant | ENST00000268097.10 | NP_000511.2 | |||
HEXA | NM_001318825.2 | c.493-1G>T | splice_acceptor_variant | NP_001305754.1 | ||||
HEXA | NR_134869.3 | n.502-1G>T | splice_acceptor_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HEXA | ENST00000268097.10 | c.460-1G>T | splice_acceptor_variant | 1 | NM_000520.6 | ENSP00000268097 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248284Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134136
GnomAD4 exome AF: 0.00000423 AC: 6AN: 1418680Hom.: 0 Cov.: 25 AF XY: 0.00000424 AC XY: 3AN XY: 708332
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74326
ClinVar
Submissions by phenotype
Tay-Sachs disease Pathogenic:5Other:1
Affects, no assertion criteria provided | literature only | OMIM | Jun 01, 1991 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Mar 17, 2017 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Nov 08, 2021 | NM_000520.4(HEXA):c.460-1G>T is a canonical splice variant classified as likely pathogenic in the context of hexosaminidase A deficiency. c.460-1G>T has been observed in cases with relevant disease (PMID: 1827945, 31388111). Functional assessments of this variant are not available in the literature. c.460-1G>T has been observed in population frequency databases (gnomAD: AFR 0.02%). In summary, NM_000520.4(HEXA):c.460-1G>T is a canonical splice variant that has been observed more frequently in cases with the relevant disease than in healthy populations. Please note: this variant was assessed in the context of healthy population screening. - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 03, 2016 | Variant summary: The HEXA c.460-1G>T variant involves the alteration of a conserved intronic nucleotide at the splice acceptor site of intron 4. One in silico tool predicts a damaging outcome for this variant. 5/5 splice prediction tools predict that this variant abolishes the 3' splicing acceptor site. This variant has been found in two patients with Tay-Sachs disease in homozygous and heterozygous state, repectively. HEX A activity in these patients was extremely low or absent. This variant was also found in 3/96942 control chromosomes at a frequency of 0.0000309, which does not exceed the estimated maximal expected allele frequency of a pathogenic HEXA variant (0.0013975). In addition, OMIM and HGMD report this variant as pathogenic/disease variant. Taken together, this variant was classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Nov 11, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 15, 2023 | This sequence change affects an acceptor splice site in intron 4 of the HEXA gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in HEXA are known to be pathogenic (PMID: 1833974, 8490625). This variant is present in population databases (rs764343937, gnomAD 0.02%). Disruption of this splice site has been observed in individual(s) with Tay-Sachs disease (PMID: 1827945). ClinVar contains an entry for this variant (Variation ID: 496011). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 27, 2023 | Canonical splice site variant predicted to result in an in-frame loss of the adjacent exon in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 31388111, 1827945) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at